| PRD_002277 | Name: | N-{(2S,4R)-2-[(1R)-3-amino-1-({N-[(2R)-2-{(1R)-1-[(N-{(2S)-2-[(1S)-3-amino-1-({N-[(3S,6R)-3-(3-amino-3-oxopropyl)-6-(hydroxymethyl)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl]-L-seryl-L-prolylglycyl}amino)-3-oxopropyl]-2,3-dihydro-1,3-thiazole-4-carbonyl}-L-alanyl)amino]-2-hydroxyethyl}-2,3-dihydro-1,3-thiazole-4-carbonyl]-L-seryl}amino)-3-oxopropyl]-1,3-oxazolidine-4-carbonyl}-L-alanyl-L-seryl-N-{(1S)-3-amino-1-[(2S)-4-{[(2S,3S)-3-hydroxy-1-oxobutan-2-yl]carbamoyl}-2,3-dihydro-1,3-thiazol-2-yl]-3-oxopropyl}-L-alaninamide | Formula: | C64 H93 N23 O25 S3 | Definition date: | 2017-08-30 | Last modified: | 2017-12-15 |
|
| PRD_002239 | Name: | N-[5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | Formula: | C32 H57 N7 O7 S | Definition date: | 2017-08-02 | Last modified: | 2023-11-03 |
|
| PRD_000041 | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-4-(2-(3-AMINOPROPYLAMINO)ETHOXY)-5-((1R,2R,3S,5R,6S)-3,5-DIAM
INO-2-((2S,3R,4R,5S,6R)-3-AMINO-4,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(
HYDROXYMETHYL)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | Formula: | C28 H57 N7 O14 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_000042 | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-DIAMINO-2-((2S,3R,4R,5S,6R)-3-AMINO-4
,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(HYDROXYMETHYL)-4-(2-((R)-PIPERIDI
N-3-YLMETHYLAMINO)ETHOXY)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | Formula: | C31 H61 N7 O14 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_000043 | Name: | DOUBLY FUNCTIONALIZED PAROMOMYCIN PM-II-162 | Formula: | C37 H65 N7 O16 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_002270 | Name: | N-{(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide | Formula: | C28 H44 N8 O5 | Definition date: | 2017-06-28 | Last modified: | 2020-06-21 |
|
| PRD_002274 | Name: | N-[(6aR,12R,15aR,17R,21R,23aR)-17,21-dimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-Nalpha-[(2E)-pent-2-enoyl]-L-phenylalaninamide | Formula: | C37 H50 N6 O8 | Definition date: | 2017-06-21 | Last modified: | 2017-06-21 |
|
| PRD_002275 | Formula: | C35 H59 N14 O13 | Definition date: | 2017-06-14 | Last modified: | 2017-12-15 |
|
| PRD_002261 | Formula: | C92 H138 N27 O24 S | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | Definition date: | 2017-05-24 | Last modified: | 2017-05-24 |
|
| PRD_002240 | Name: | 18-methoxy-2,11,17-trimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C30 H44 N4 O6 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002241 | Name: | 3-[(3-hydroxyphenyl)methyl]-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | Formula: | C30 H42 N4 O6 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002245 | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-17-methyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C35 H46 N4 O7 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002246 | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-2,17-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | Formula: | C36 H48 N4 O7 | Definition date: | 2017-01-25 | Last modified: | 2017-01-25 |
|
| PRD_002251 | Name: | 3-[(3-hydroxyphenyl)methyl]-10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | Formula: | C34 H50 N4 O8 | Definition date: | 2017-01-25 | Last modified: | 2017-05-04 |
|
| PRD_002248 | Name: | (4S,7S,17R)-7-(hydroxymethyl)-4-(2-methylpropyl)-17-pentyl-1-oxa-3,6,11-triazacycloheptadecane-2,5,10-trione | Formula: | C23 H43 N3 O5 | Definition date: | 2017-01-11 | Last modified: | 2017-01-11 |
|
| PRD_002249 | Name: | (4S,7S,17S)-17-(3-chlorophenyl)-7-(hydroxymethyl)-4-(2-methylpropyl)-1-oxa-3,6,11-triazacycloheptadecane-2,5,10-trione | Formula: | C24 H36 Cl N3 O5 | Definition date: | 2017-01-11 | Last modified: | 2017-01-11 |
|
| PRD_002253 | Name: | (2S)-N-{(2S)-3-methoxy-1-[(naphthalen-1-ylmethyl)amino]-1-oxopropan-2-yl}-4-oxo-2-[(3-phenylpropanoyl)amino]-4-(1H-pyrrol-1-yl)butanamide (non-preferred name) | Formula: | C32 H34 N4 O5 | Definition date: | 2017-01-11 | Last modified: | 2023-11-03 |
|
| PRD_002254 | Name: | (2~{S})-~{N}-[(2~{S})-3-methoxy-1-(naphthalen-1-ylmethylamino)-1-oxidanylidene-propan-2-yl]-4-oxidanylidene-2-(3-phenylpropanoylamino)-4-piperidin-1-yl-butanamide | Formula: | C33 H40 N4 O5 | Definition date: | 2017-01-11 | Last modified: | 2023-11-03 |
|
| PRD_002256 | Name: | N-tert-butoxy-N~2~-(5-methyl-1,2-oxazole-3-carbonyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | Formula: | C28 H35 N5 O7 | Definition date: | 2017-01-11 | Last modified: | 2023-11-03 |
|
| PRD_002183 | Name: | (2S,5S,8S,14R,17E)-2-(cyclohexylmethyl)-5-(4-fluorobenzyl)-8-(4-nitrobenzyl)-3,6,9,16,19-pentaoxo-1,4,7,10,15-pentaazacyclononadec-17-ene-14-carboxylic acid | Formula: | C36 H43 F N6 O9 | Definition date: | 2016-09-21 | Last modified: | 2023-11-03 |
|
| PRD_002186 | Name: | 6-ammonio-N-[3-(9H-fluoren-9-yl)propanoyl]-L-norleucyl-6-ammonio-L-norleucyl-L-alpha-glutamyl-L-threonyl-L-alpha-glutamyl-L-valine | Formula: | C47 H70 N8 O13 | Definition date: | 2016-08-17 | Last modified: | 2016-08-17 |
|
| PRD_002173 | Name: | N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C39 H67 N5 O7 | Definition date: | 2016-07-27 | Last modified: | 2023-11-03 |
|
| PRD_002175 | Name: | N,beta,beta-trimethyl-L-phenylalanyl-N-[(3S,4Z)-5-carboxy-2-methylhex-4-en-3-yl]-N,3-dimethyl-L-valinamide | Formula: | C27 H43 N3 O4 | Definition date: | 2016-07-27 | Last modified: | 2016-07-27 |
|
| PRD_002204 | Formula: | C21 H34 N4 O7 | Definition date: | 2016-07-27 | Last modified: | 2023-11-03 |
|
| PRD_002237 | Name: | (2R,4R)-4-{[(2-{(1R,3R)-1-(acetyloxy)-4-methyl-3-[methyl(N-{[(2S)-1-methylpiperidin-2-yl]carbonyl}-D-isoleucyl)amino]pentyl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoic acid | Formula: | C38 H57 N5 O7 S | Definition date: | 2016-07-27 | Last modified: | 2016-07-27 |
|